Normunity

Normunity is a clinical-stage biotechnology company developing novel anti-cancer therapies that work at the interface of the immune system and the tumor. In collaboration with the Lieping Chen lab at the Yale School of Medicine, Normunity has identified a novel class of "Immuno-smart targets" — tumor-specific, cell-surface proteins co-opted by cancer cells to drive local immune suppression — and is building a pipeline of biologic medicines including therapeutic antibodies, bispecific antibodies, and payload-carrying biologics. Its lead program, NRM-823, is a T cell engager that has entered clinical trials. Normunity is backed by Canaan Partners. This is a corporate/scientific company with no public API, developer portal, or programmatic surface.

Normunity is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Immuno-Oncology, Oncology, and Cancer.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyImmuno-OncologyOncologyCancerTherapeuticsImmunologyAntibodiesClinical TrialsPharmaceuticals

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/normunity: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Website

Website

LinkedIn

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

aid: normunity
name: Normunity
description: Normunity is a clinical-stage biotechnology company developing novel anti-cancer therapies that work at the interface
  of the immune system and the tumor. In collaboration with the Lieping Chen lab at the Yale School of Medicine, Normunity
  has identified a novel class of "Immuno-smart targets" — tumor-specific, cell-surface proteins co-opted by cancer cells
  to drive local immune suppression — and is building a pipeline of biologic medicines including therapeutic antibodies, bispecific
  antibodies, and payload-carrying biologics. Its lead program, NRM-823, is a T cell engager that has entered clinical trials.
  Normunity is backed by Canaan Partners. This is a corporate/scientific company with no public API, developer portal, or
  programmatic surface.
url: https://raw.githubusercontent.com/api-evangelist/normunity/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Immuno-Oncology
- Oncology
- Cancer
- Therapeutics
- Immunology
- Antibodies
- Clinical Trials
- Pharmaceuticals
image: https://normunity.com/wp-content/uploads/2022/10/normunity-logo.png
apis: []
common:
- type: Website
  url: https://normunity.com/
- type: X
  url: https://x.com/normunity
- type: LinkedIn
  url: https://www.linkedin.com/company/normunity
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1
  note: Clinical-stage immuno-oncology biotech; no public API, developer portal, or programmatic surface. Identity hygiene
    enriched; domain probed.